Last reviewed · How we verify
NCT05774587
Mobile Health for Cardiac Rehabilitation (Motivate-CR+)
NA trial testing mHealth control group in Cardiac Event in 63 participants. Completed in 1 May 2025.
1 May 2025
Quick facts
| Lead sponsor | Liverpool John Moores University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 63 |
| Start date | 6 July 2023 |
| Primary completion | 1 May 2025 |
| Estimated completion | 1 May 2025 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- mHealth control group
- mHealth technology assisted exercise counselling (mHealth)
Conditions studied
- Cardiac Event — all drugs for Cardiac Event →
Sponsor
Liverpool John Moores University
Who can join
18 and older, any sex, with Cardiac Event. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators aim to conduct a feasibility study to evaluate a model where mobile health (mHealth) technology supports a remote home-based PA and counselling intervention immediately post hospital discharge to increase uptake to cardiac rehabilitation. Our overall objective is to test the feasibility of an evidence-based complex intervention prior to evaluation in a future randomized control trial (RCT)
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
<u>Mo</u>bile heal<u>t</u>h <u>bi</u>ometrics to prescribe immediate remote physical acti<u>v</u>ity for enh<u>a</u>ncing up<u>t</u>ak<u>e</u> to <u>c</u>ardiac <u>r</u>eha
Crozier A, Cocks M, Hesketh K, Miller G, et al · · 2024 · PMID 38346877 · DOI 10.1136/bmjopen-2023-076734
Verify or expand the search:
- PubMed search for NCT05774587
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiac Event
Currently open trials in the same condition.
- NCT04696523 — Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage · Phase 2 · recruiting
- NCT06666400 — Living Healthy for Moms RCT · NA · active not recruiting
Other Liverpool John Moores University trials
Trials by the same sponsor.
- NCT07454317 — Biofeedback Intervention for Paroxysmal Atrial Fibrillation · NA · not yet recruiting
- NCT07469852 — Effects of Caffeine Ingestion on Morning Cognitive and 4-km Time Trial Performance in Males · Phase 1, PHASE2 · active not recruiting
- NCT07366931 — The Effect of Daily Supplementation With Humiome® Post LB on Gastrointestinal Symptoms in Female Athletes · Phase 1, PHASE2 · not yet recruiting
- NCT07466732 — Effects of Caffeine Ingestion on Morning Cognitive and Muscle Repeated Sprint Performance in Males · EARLY_PHASE1 · enrolling by invitation
- NCT07341243 — Exercising in Hot Conditions: How Does it Effect Blood Glucose in People With T1D · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05774587 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Liverpool John Moores University
- Last refreshed: 15 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05774587.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing